176 related articles for article (PubMed ID: 15883282)
41. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
43. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
Cheung CY; Chan HW; Liu YL; Chau KF; Li CS
Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
[TBL] [Abstract][Full Text] [Related]
44. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
[TBL] [Abstract][Full Text] [Related]
45. Posterior segment involvement in Korean patients with HLA-B27-associated uveitis.
Kim SJ; Chung H; Yu HG
Ocul Immunol Inflamm; 2009; 17(1):26-32. PubMed ID: 19294570
[TBL] [Abstract][Full Text] [Related]
46. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients.
Serón D; O'Valle F; Moreso F; Gomà M; Hueso M; Grinyó JM; Garcia del Moral R
Transplantation; 2007 Mar; 83(5):649-52. PubMed ID: 17353788
[TBL] [Abstract][Full Text] [Related]
48. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis.
Tanner V; Kanski JJ; Frith PA
Eye (Lond); 1998; 12 ( Pt 4)():679-85. PubMed ID: 9850264
[TBL] [Abstract][Full Text] [Related]
49. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Gelens MA; Christiaans MH; v Hooff JP
Transplant Proc; 2005 May; 37(4):1900-1. PubMed ID: 15919498
[TBL] [Abstract][Full Text] [Related]
50. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
[TBL] [Abstract][Full Text] [Related]
51. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
[TBL] [Abstract][Full Text] [Related]
53. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
54. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
55. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
[TBL] [Abstract][Full Text] [Related]
56. CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens.
Charco R; Caragol I; Urbán S; Lázaro JL; Murio E; Dávila R; Margarit C
Transplant Proc; 1999 Dec; 31(8):3365-6. PubMed ID: 10616508
[No Abstract] [Full Text] [Related]
57. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
[TBL] [Abstract][Full Text] [Related]
58. Immune Profiling of T Cells Infiltrating Vitreous Humor in Tubercular Uveitis.
Sharma RK; Gupta V; Bansal R; Sharma K; Gupta A; Sachdeva N
Immunol Invest; 2018 Aug; 47(6):615-631. PubMed ID: 29733740
[TBL] [Abstract][Full Text] [Related]
59. Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.
Plskova J; Greiner K; Forrester JV
Am J Ophthalmol; 2007 Jul; 144(1):55-61. PubMed ID: 17601428
[TBL] [Abstract][Full Text] [Related]
60. Assessment of health-related quality-of-life in patients after heart transplantation under therapy with tacrolimus or cyclosporine.
von Steinbüchel N; Limm H; Leopold C; Carr D
Transpl Int; 2000; 13 Suppl 1():S609-14. PubMed ID: 11112084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
